Journal Title:Annals Of Coloproctology
Annals of Coloproctology is an academic journal dedicated to the field of colorectal disease, providing a platform for researchers, clinical doctors, and related medical professionals to exchange and share the latest research results, clinical experience, technological advancements, and treatment strategies. This journal aims to promote the dissemination of knowledge and professional development in the field of colorectal diseases, particularly in the research and treatment of colorectal cancer, inflammatory bowel disease, functional bowel disease, pelvic floor dysfunction, and other related diseases. Journal content typically includes original research papers, review articles, technical reports, clinical case analyses, and reviews, covering a wide range of topics such as molecular biology of colorectal cancer, genetics, diagnostic techniques, surgical methods, radiotherapy and chemotherapy strategies, and management of inflammatory bowel disease.
The editorial team of the journal is usually composed of experts and scholars in the field of colorectal diseases, who are responsible for the editorial work of the journal, including article collection, peer review, and final publication. The journal adopts a strict peer review process to ensure that the published articles have high quality and academic value. Due to the interdisciplinary nature of colorectal diseases, including surgery, internal medicine, radiology, pathology, and basic sciences, the journal provides readers with an opportunity to understand colorectal diseases and treatment methods from multiple perspectives. By reading and publishing articles in this journal, readers can learn about the latest research trends in colorectal diseases, innovations in clinical practice, and improvements in treatment strategies.
《結(jié)直腸病學(xué)年鑒》是一本專注于結(jié)直腸病學(xué)領(lǐng)域的學(xué)術(shù)期刊,它為結(jié)直腸病學(xué)的研究者、臨床醫(yī)生和相關(guān)醫(yī)療專業(yè)人員提供了一個(gè)交流和分享最新研究成果、臨床經(jīng)驗(yàn)、技術(shù)進(jìn)展和治療策略的平臺(tái)。該期刊旨在推動(dòng)結(jié)直腸病學(xué)領(lǐng)域的知識(shí)傳播和專業(yè)發(fā)展,特別是在結(jié)直腸癌、炎癥性腸病、功能性腸病、盆底功能障礙和其他相關(guān)疾病的研究和治療方面。期刊內(nèi)容通常包括原創(chuàng)研究論文、綜述文章、技術(shù)報(bào)告、臨床案例分析和評(píng)論,涵蓋了廣泛的主題,如結(jié)直腸癌的分子生物學(xué)、遺傳學(xué)、診斷技術(shù)、外科手術(shù)方法、放療和化療策略、以及炎癥性腸病的管理等。
雜志的編輯團(tuán)隊(duì)通常由結(jié)直腸病學(xué)領(lǐng)域的專家和學(xué)者組成,他們負(fù)責(zé)期刊的編輯工作,包括文章的征集、同行評(píng)審以及最終的出版。期刊采用嚴(yán)格的同行評(píng)審流程,確保發(fā)表的文章具有高質(zhì)量和學(xué)術(shù)價(jià)值。由于結(jié)直腸病學(xué)是一個(gè)涉及多學(xué)科交叉的領(lǐng)域,包括外科、內(nèi)科、放射學(xué)、病理學(xué)和基礎(chǔ)科學(xué)等,雜志為讀者提供了一個(gè)多角度理解結(jié)直腸疾病和治療方法的機(jī)會(huì)。通過(guò)閱讀和發(fā)表在該期刊上的文章,讀者可以了解結(jié)直腸病學(xué)的最新研究趨勢(shì)、臨床實(shí)踐的創(chuàng)新和治療策略的改進(jìn)。
Annals Of Coloproctology由Korean Society of Coloproctology出版商出版,收稿方向涵蓋Multiple全領(lǐng)域,平均審稿速度 18 Weeks ,影響因子指數(shù)3,該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單,廣大學(xué)者值得一試。
按JIF指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:GASTROENTEROLOGY & HEPATOLOGY | ESCI | Q2 | 54 / 143 |
62.6% |
學(xué)科:SURGERY | ESCI | Q1 | 47 / 290 |
84% |
按JCI指標(biāo)學(xué)科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學(xué)科:GASTROENTEROLOGY & HEPATOLOGY | ESCI | Q2 | 42 / 143 |
70.98% |
學(xué)科:SURGERY | ESCI | Q2 | 100 / 290 |
65.69% |
名詞解釋:
WOS即Web of Science,是全球獲取學(xué)術(shù)信息的重要數(shù)據(jù)庫(kù),Web of Science包括自然科學(xué)、社會(huì)科學(xué)、藝術(shù)與人文領(lǐng)域的信息,來(lái)自全世界近9,000種最負(fù)盛名的高影響力研究期刊及12,000多種學(xué)術(shù)會(huì)議多學(xué)科內(nèi)容。給期刊分區(qū)時(shí)會(huì)按照某一個(gè)學(xué)科領(lǐng)域劃分,根據(jù)這一學(xué)科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會(huì)在高分區(qū)中,最后的劃分結(jié)果分別是Q1,Q2,Q3,Q4,Q1代表質(zhì)量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||
3.3 | 0.481 | 0.855 |
|
名詞解釋:
CiteScore:衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)。
SJR:SCImago 期刊等級(jí)衡量經(jīng)過(guò)加權(quán)后的期刊受引用次數(shù)。引用次數(shù)的加權(quán)值由施引期刊的學(xué)科領(lǐng)域和聲望 (SJR) 決定。
SNIP:每篇文章中來(lái)源出版物的標(biāo)準(zhǔn)化影響將實(shí)際受引用情況對(duì)照期刊所屬學(xué)科領(lǐng)域中預(yù)期的受引用情況進(jìn)行衡量。
是否OA開放訪問(wèn): | h-index: | 年文章數(shù): |
未開放 | -- | 66 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來(lái)源于搜索引擎): | 開源占比(OA被引用占比): |
99.49% | 3 | |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國(guó)際期刊預(yù)警名單(試行)》名單: |
84.85% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標(biāo)和發(fā)文量:
歷年自引數(shù)據(jù):
若用戶需要出版服務(wù),請(qǐng)聯(lián)系出版商。